You have platinum-resistant ovarian cancer. This means that it came back or progressed after certain types of chemotherapy
Your cancer is positive for a type of biomarker protein called
folate receptor alpha, or
FRalpha (FRα)
Before you start treatment, your doctor will test your tissue sample to confirm that your cancer is positive for FRα. To do this, your doctor can use tumor tissue stored from an earlier biopsy or surgery or take a new sample
How does ELAHERE kill cancer cells?
ELAHERE is the first and only FRα-targeted treatment for platinum-resistant ovarian cancer
ELAHERE attaches to the outside of the cancer cell
After binding to FRα, ELAHERE is taken into the cell
ELAHERE releases a strong cancer-killing drug inside the cancer cell
The cancer-killing drug can also impact other nearby cells that may be cancerous
ELAHERE is a type of treatment called an antibody-drug conjugate (ADC). ADCs are different from traditional chemotherapies and are designed to treat cancer in a targeted way